Fred Kerwood

Fred Kerwood's Title

Fred Kerwood currently holds the esteemed position of Vice President of Program Management. In this role, he leverages his extensive experience to oversee and streamline various programs, ensuring their successful execution and alignment with organizational goals. His leadership in this capacity underscores his strategic vision and deep understanding of program management within the pharmaceutical industry.

Fred Kerwood's Experience

Fred Kerwood brings over 30 years of program management and clinical operations experience to the pharmaceutical industry. His vast expertise spans across overseeing complex clinical trials, leading cross-functional teams, and driving strategic initiatives. This extensive background has equipped him with a nuanced understanding of the intricacies involved in pharmaceutical program management, making him a valuable asset to any organization.

Fred Kerwood's Role at CytomX Therapeutics

At CytomX Therapeutics, Fred Kerwood served as the Vice President of Clinical Operations. In this role, he was instrumental in the execution of the company's oncology programs, including a pivotal Phase 2 program focused on breast cancer. His leadership and strategic oversight were crucial in navigating the complexities of clinical trials and advancing the company's therapeutic pipeline.

Fred Kerwood's Tenure at Immune Design

Fred Kerwood also held the position of Vice President of Project Management and Clinical Operations at Immune Design, a subsidiary of Merck. During his tenure, he managed immuno-oncology projects, contributing to the development of innovative cancer therapies. His role involved coordinating various project phases and ensuring alignment with regulatory standards, thus driving the company's mission to bring novel treatments to market.

Fred Kerwood's Education and Expertise

Fred Kerwood holds an MBA in Science and Technology from LaSalle University, complementing his technical and strategic acumen. He also earned a Bachelor of Science degree in Psychology/Biochemistry from Texas A&M University. This diverse educational background provides him with a unique perspective, blending scientific knowledge with business strategy, which he effectively applies in his current and past roles.